Company

VOIS

APrevent won 2024 MedTech Innovator Asia Pacific Grand Finals

2024-09-13

APrevent recently achieved a significant milestone by winning the prestigious 2024 MedTech Innovator Asia Pacific Grand Finals. This annual competition, which supports medtech startups through mentorship and funding opportunities, culminated with APrevent being awarded the top prize of $175,000. The competition, held in collaboration with the Asia Pacific Medical Technology Association (APACMed), saw APrevent recognized for its innovative solutions addressing voice and speech disorders, a pressing need in healthcare.

 

APrevent was selected from over 400 companies that applied to the program, with only 60 advancing to the pitching stage. Following rigorous assessments, 20 companies completed the four-month accelerator program. APrevent emerged victorious after presenting its cutting-edge technology to a panel of industry experts and a live audience vote at the APACMed MedTech Forum in Singapore.

 

This recognition highlights APrevent's commitment to revolutionizing the medtech space, specifically in providing life-changing technologies for individuals with speech difficulties. The competition also spotlighted other medtech startups like INOPASE and Qritive, who won additional awards for their contributions to healthcare innovation.

 

The MedTech Innovator program, which fosters growth for early to mid-stage startups, has helped over 700 companies raise substantial funding and introduce products to the global market. APrevent's win marks a crucial step forward in its mission to improve patient care, aligning with the broader goals of advancing medtech innovation across Asia Pacific.

 

This achievement not only strengthens APrevent's position in the medtech industry but also opens doors to further collaboration and investment opportunities within the region.